These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21335297)

  • 41. An integrated care facilitation model improves quality of life and reduces use of hospital resources by patients with chronic obstructive pulmonary disease and chronic heart failure.
    Bird S; Noronha M; Sinnott H
    Aust J Prim Health; 2010; 16(4):326-33. PubMed ID: 21138701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. COPD management in primary care: an observational, community pharmacy-based study.
    Mehuys E; Boussery K; Adriaens E; Van Bortel L; De Bolle L; Van Tongelen I; Remon JP; Brusselle G
    Ann Pharmacother; 2010 Feb; 44(2):257-66. PubMed ID: 20103611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cost of treating patients with COPD in Denmark--a population study of COPD patients compared with non-COPD controls.
    Bilde L; Rud Svenning A; Dollerup J; Baekke Borgeskov H; Lange P
    Respir Med; 2007 Mar; 101(3):539-46. PubMed ID: 16889949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
    Lee TA; Schumock GT; Bartle B; Pickard AS
    Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Costs of COPD exacerbations in the emergency department and inpatient setting.
    Dalal AA; Shah M; D'Souza AO; Rane P
    Respir Med; 2011 Mar; 105(3):454-60. PubMed ID: 20869226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regions with higher Medicare Part D spending show better drug adherence, but not lower medicare costs for two diseases.
    Stuart B; Shoemaker JS; Dai M; Davidoff AJ
    Health Aff (Millwood); 2013 Jan; 32(1):120-6. PubMed ID: 23297279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease.
    Qian J; Simoni-Wastila L; Rattinger GB; Zuckerman IH; Lehmann S; Wei YJ; Stuart B
    Int J Geriatr Psychiatry; 2014 Jan; 29(1):49-57. PubMed ID: 23606418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COPD costs to approach $50B per year in 2020.
    Manag Care; 2014 Sep; 23(9):57. PubMed ID: 25282870
    [No Abstract]   [Full Text] [Related]  

  • 50. Plans breathe life into COPD efforts.
    Kirsch B
    Manag Care; 2011 Jun; 20(6):36-8, 41. PubMed ID: 21739923
    [No Abstract]   [Full Text] [Related]  

  • 51. Adherence and healthcare utilization among older adults with COPD and depression.
    Albrecht JS; Khokhar B; Huang TY; Wei YJ; Harris I; Moyo P; Hur P; Lehmann SW; Netzer G; Simoni-Wastila L
    Respir Med; 2017 Aug; 129():53-58. PubMed ID: 28732836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does medication adherence lower Medicare spending among beneficiaries with diabetes?
    Zimmerman C
    Find Brief; 2011 Jul; 14(5):1-3. PubMed ID: 21780329
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of coverage gap on healthcare utilization among Medicare beneficiaries with chronic obstructive pulmonary disorder.
    Sansgiry SS; Bhansali A; Serna O; Kamdar M; Fleming M; Abughosh S; Stanford RH
    Curr Med Res Opin; 2019 Feb; 35(2):321-328. PubMed ID: 29962241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Counting costs in COPD: what do the numbers mean?
    Mannino DM
    Chest; 2015 Jan; 147(1):3-5. PubMed ID: 25560850
    [No Abstract]   [Full Text] [Related]  

  • 55. Chronic obstructive pulmonary disease in the elderly: identifying the knowledge gaps to support research and clinical practice guidelines.
    Blasi F; Guffanti EE
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S55. PubMed ID: 22209932
    [No Abstract]   [Full Text] [Related]  

  • 56. Geographic disparities in chronic obstructive pulmonary disease (COPD) hospitalization among Medicare beneficiaries in the United States.
    Holt JB; Zhang X; Presley-Cantrell L; Croft JB
    Int J Chron Obstruct Pulmon Dis; 2011; 6():321-8. PubMed ID: 21697996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [How the care of COPD will be better].
    Larsson K; Löfdahl CG; Lindén A; Sandström T; Johansson GS
    Lakartidningen; 2011 Aug 31-Sep 6; 108(35):1604-5. PubMed ID: 22043614
    [No Abstract]   [Full Text] [Related]  

  • 58. Guidelines versus clinical practice in the treatment of COPD: a reappraisal.
    Riario-Sforza GG; Incorvaia C; Pravettoni C; Dugnani N
    Eur Respir J; 2006 Mar; 27(3):656. PubMed ID: 16507872
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of BMI on health care expenditures stratified by COPD GOLD severity grades: Results from the LQ-DMP study.
    Kirsch F; Schramm A; Kurz C; Schwarzkopf L; Lutter JI; Huber M; Leidl R
    Respir Med; 2020 Dec; 175():106194. PubMed ID: 33166903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Omaha and OASIS. A comparative study of outcomes in patients with chronic obstructive pulmonary disease.
    McGourthy RJ
    Home Care Provid; 1999 Feb; 4(1):21-5. PubMed ID: 10222933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.